Literature DB >> 8653833

Heart transplantation-associated perioperative ischemic myocardial injury. Morphological features and clinical significance.

B Fyfe1, E Loh, G L Winters, G S Couper, A I Kartashov, F J Schoen.   

Abstract

BACKGROUND: The frequency and clinical significance of perioperative ischemic myocardial injury (PIMI) after heart transplantation and the diagnostic features distinguishing PIMI from rejection are not well defined. METHODS AND
RESULTS: We evaluated PIMI in the first four weekly endomyocardial biopsies and/or autopsy myocardium from 140 consecutive orthotopic heart transplantation recipients (1984 to 1991) by grading the severity of coagulative myocyte necrosis (CMN) as absent, 0; mild-focal, 1; moderate-multifocal, 2; or severe-confluent, 3, and determining the evolution of morphological features of its healing. CMN (often with contraction bands) was noted in 124 patients (89%); 24 patients (17%) had grade 3 CMN, of which 4 died within 30 days of transplantation. Nevertheless, at 1 year after surgery, survival was similar in patients with and without severe injury. Increased cold ischemic time but neither donor age nor intensity of inotropic support correlated with more severe early ischemic injury. PIMI inflammation was characterized by a predominantly polymorphonuclear/histiocytic infiltrate that contained lymphocytes and plasma cells, expanding the interstitium but not encroaching upon and separable from adjacent viable myocytes. Histological features of PIMI developed and resolved more slowly than those of typical myocardial infarct necrosis in nonimmunosuppressed patients; at 4 weeks, CMN persisted in 20% of patients and residual healing in nearly half. Diagnostic rejection was observed concurrently with PIMI in 54 of 533 biopsies (10%).
CONCLUSIONS: Diagnosed by conventional histological criteria, PIMI is prevalent early after heart transplantation and has a protracted healing phase that can mimic or coexist with rejection. Extensive PIMI has deleterious impact on short-term survival, but the long-term impact of PIMI remains to be established.

Entities:  

Mesh:

Year:  1996        PMID: 8653833     DOI: 10.1161/01.cir.93.6.1133

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  The human heart: a self-renewing organ.

Authors:  Jan Kajstura; Toru Hosoda; Claudia Bearzi; Marcello Rota; Silvia Maestroni; Konrad Urbanek; Annarosa Leri; Piero Anversa
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

2.  Sequential evolution of IL-17 responses in the early period of allograft rejection.

Authors:  Sang Il Min; Jongwon Ha; Chung-Gyu Park; Jae Kyung Won; Yang Jin Park; Seung-Kee Min; Sang Joon Kim
Journal:  Exp Mol Med       Date:  2009-10-31       Impact factor: 8.718

Review 3.  New concepts of complement in allorecognition and graft rejection.

Authors:  Barbara A Wasowska; Chih-Yuan Lee; Marc K Halushka; William M Baldwin
Journal:  Cell Immunol       Date:  2007-10-24       Impact factor: 4.868

4.  Diagnostic Pitfalls and Challenges in Interpretation of Heart Transplantation Rejection in Endomyocardial Biopsies With Focus on our Experience.

Authors:  Kambiz Mozaffari; Hooman Bakhshandeh; Ahmad Amin; Nasim Naderi; Sepideh Taghavi; Zahra Ojaghi-Haghighi; Mahsa Abdollahi
Journal:  Res Cardiovasc Med       Date:  2014-02-24

Review 5.  From Protecting the Heart to Improving Athletic Performance - the Benefits of Local and Remote Ischaemic Preconditioning.

Authors:  Vikram Sharma; Reuben Marsh; Brian Cunniffe; Marco Cardinale; Derek M Yellon; Sean M Davidson
Journal:  Cardiovasc Drugs Ther       Date:  2015-12       Impact factor: 3.727

6.  Impact of cold ischemia on mitochondrial function in porcine hearts and blood vessels.

Authors:  Dominik Wiedemann; Thomas Schachner; Nikolaos Bonaros; Melissa Dorn; Martin Andreas; Alfred Kocher; Andrey V Kuznetsov
Journal:  Int J Mol Sci       Date:  2013-11-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.